Data gathered: November 21
AI Stock Analysis - Teleflex (TFX)
Analysis generated November 7, 2024. Powered by Chat GPT.
Teleflex Incorporated is a global provider of medical technologies designed to improve the health and quality of people's lives. The company specializes in critical care and surgical product development, such as vascular access products, respiratory devices, and surgical instruments. Headquartered in Wayne, Pennsylvania, Teleflex operates through a network of subsidiaries and has established a reputable presence in the healthcare sector.
Stock Alerts - Teleflex (TFX)
 |
Teleflex | November 1 Price is up by 5.1% in the last 24h. |
|
Teleflex | October 31 Price is down by -12.5% in the last 24h. |
|
Teleflex | September 2 Job postings are down by 46.4% in the last couple of days. |
|
Teleflex | September 1 Job postings are down by 45.9% in the last couple of days. |
Alternative Data for Teleflex
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 170 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 130,000 | Sign up | Sign up | Sign up |
| Employee Rating | 80 | Sign up | Sign up | Sign up |
| Google Trends | 64 | Sign up | Sign up | Sign up |
| Patents | 164 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Instagram Followers | 1,106 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 395 | Sign up | Sign up | Sign up |
| Twitter Mentions | 39 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Lobbying Cost | $10,000 | Sign up | Sign up | Sign up |
| Business Outlook | 73 | Sign up | Sign up | Sign up |
| Linkedin Employees | 8,554 | Sign up | Sign up | Sign up |
About Teleflex
Teleflex, Inc. provides medical technology products which enables healthcare providers to improve patient outcomes and enhance patient and provider safety. The company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications.
| Price | $190.64 |
| Target Price | Sign up |
| Volume | 360,020 |
| Market Cap | $8.97B |
| Year Range | $187.43 - $247.32 |
| Dividend Yield | 0.7% |
| PE Ratio | 38.31 |
| Analyst Rating | 50% buy |
| Industry | Health Care Services |
In the news
 |
Teleflex Incorporated (NYSE:TFX) Shares Sold by Kentucky Retirement Systems Insurance Trust FundNovember 20 - ETF Daily News |
|
Teleflex (NYSE:TFX) Rating Lowered to “Hold” at StockNews.comNovember 20 - ETF Daily News |
|
KBC Group NV Raises Stock Position in Teleflex Incorporated (NYSE:TFX)November 19 - ETF Daily News |
 |
Here's Why Teleflex (TFX) is a Strong Value StockNovember 18 - Yahoo |
 |
Teleflex to Present at the 36th Annual Piper Sandler Healthcare ConferenceNovember 18 - Yahoo |
|
Apollon Wealth Management LLC Grows Position in Teleflex Incorporated (NYSE:TFX)November 18 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 764M | 576M | 430M | 111M | 198M | 3.490 |
| Q2 '24 | 750M | 592M | 416M | 80M | 168M | 3.420 |
| Q1 '24 | 719M | 755M | 416M | 15M | 47M | 3.210 |
| Q4 '23 | 751M | 761M | 431M | 31M | 203M | 3.380 |
| Q3 '23 | 723M | 544M | 416M | 137M | 214M | 3.640 |
Insider Transactions View All
| RANDLE STUART A filed to sell 5,496 shares at $238.9. August 16 '24 |
| Hicks Cameron P filed to sell 10,050 shares at $225. March 5 '24 |
| Kelly Liam filed to sell 18,470 shares at $251.2. December 29 '23 |
| Kelly Liam filed to sell 21,141 shares at $250.1. December 29 '23 |
| POWELL THOMAS E filed to sell 14,384 shares at $224.1. December 1 '23 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Rohit Khanna Democrat |
May 6, 24 | Buy | $1K - $15K |
| Rohit Khanna Democrat |
Nov 8, 23 | Sell | $1K - $15K |
| Rohit Khanna Democrat |
Sep 6, 23 | Buy | $1K - $15K |
Read more about Teleflex (TFX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Teleflex?
The Market Cap of Teleflex is $8.97B.
What is Teleflex's PE Ratio?
As of today, Teleflex's PE (Price to Earnings) ratio is 38.31.
What is the current stock price of Teleflex?
Currently, the price of one share of Teleflex stock is $190.64.
How can I analyze the TFX stock price chart for investment decisions?
The TFX stock price chart above provides a comprehensive visual representation of Teleflex's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Teleflex shares. Our platform offers an up-to-date TFX stock price chart, along with technical data analysis and alternative data insights.
Does TFX offer dividends to its shareholders?
Yes, Teleflex (TFX) offers dividends to its shareholders, with a dividend yield of 0.7%. This dividend yield represents Teleflex's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Teleflex in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Teleflex?
Some of the similar stocks of Teleflex are Abbott Laboratories, HCA Healthcare, Cardinal Health, Henry Schein, and Idexx Laboratories.
.